Headshot of Sherman Hom

Sherman Hom, PhD
Director, Regulatory Affairs
Medicinal Genomics
POSTER PRESENTER
SAFETY

What you have been waiting for!
2024 Update to the All-States’ Cannabis Testing Regulations

The purpose of this study was to update the 2022 “All States Cannabis Microbial Required Testing Compendium” and to update and expand our analyses of the required microbial testing regulations for the four primary cannabis product types - flower, concentrate, infused edibles, and infused non-edibles. All analyses were performed to record the state of cannabis microbial testing regulations in all US jurisdictions, identify testing trends over a 4 year period, and identify a consensus set of required tests to reduce public health risk.

The regulations for medical and adult-use cannabis programs in all legalized U.S. jurisdictions were reviewed. For each jurisdiction, a list of required microbial tests with the corresponding action level was recorded for each product type. Comparative analyses were conducted within each product type (flower, concentrate, edibles, and non-edibles) and the data from 2019 & 2023 were compared for microbial testing of flower product samples.

Learning Objectives:

1. For 4 cannabis product types, the number of required microbial tests, action levels, and test combinations varies from state to state.

2. A national cannabis flower microbiome study can identify all the human pathogens that may allow an expert panel to propose a single microbial testing regimen.

BIO
Dr. Sherman Hom is the Director of Regulatory Affairs at Medicinal Genomics Corporation (MGC) that markets genetics-based cannabis tests and breeding technologies. At MGC, Sherman provides recommendations to cannabis regulatory agency officials that are tasked with drafting and/or modifying cannabis, hemp, and psychedelic mushroom microbial testing regulations to ensure safe products for patients and consumers. He is a member of the AOAC Cannabis Science Program, ASTM International D37 Cannabis Committee, Association of Food and Drug Officials Cannabis Committee, National Cannabis Laboratory Council, and the Colorado Public Health and Environment Cannabis Science and Policy Forum. Before MGC, he worked at the New Jersey Department of Health, Division of Public Health & Environmental Laboratories for 21+ years as a Program Manager of various clinical diagnostic testing units, which included the Cannabis Laboratory Microbial Testing Laboratory. Sherman received his B.A in Biology from the University of California at San Diego, PhD in Microbiology from the University of California at Davis, and was a Postdoctoral Fellow in Molecular Genetics at The John Hopkins University.

ATTENDANCE IS LIMITED. THE OPPORTUNITIES ARE NOT.

Image